(Q51776850)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19902989%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

title

Population pharmacokinetic modelling of filgrastim in healthy adults following intravenous and subcutaneous administrations (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19902989%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19902989%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Philip J Lowe

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19902989%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

author name string

Etienne Pigeolet

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19902989%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Frank Lüdicke

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19902989%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Sigrid Balser

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19902989%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Wojciech Krzyzanski

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19902989%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

publication date

1 January 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19902989%20AND%20SRC:MED&resulttype=core&format=json

Clinical Pharmacokinetics

12 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19902989%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

volume

48

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19902989%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19902989%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

page(s)

817-826

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19902989%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.2165/11318090-000000000-00000

12 February 2020

exact match

0 references

cites work

An overview of the pharmacokinetics and pharmacodynamics of efalizumab: a monoclonal antibody approved for use in psoriasis

1 reference

12 December 2020

Binding of 125I-labeled granulocyte colony-stimulating factor to normal murine hemopoietic cells

1 reference

12 December 2020

Target-mediated pharmacokinetic and pharmacodynamic model of recombinant human erythropoietin (rHuEPO).

1 reference

12 December 2020

Biologic and molecular effects of granulocyte colony-stimulating factor in healthy individuals: recent findings and current challenges

1 reference

12 December 2020

General pharmacokinetic model for drugs exhibiting target-mediated drug disposition

1 reference

12 December 2020

Pharmacokinetic/pharmacodynamic modeling of pegfilgrastim in healthy subjects

1 reference

12 December 2020

Pharmacokinetics/pharmacodynamics of nondepleting anti-CD4 monoclonal antibody (TRX1) in healthy human volunteers

1 reference

12 December 2020

Pharmacologic target-mediated drug disposition

1 reference

12 December 2020

Granulocyte colony-stimulating factor and its receptor

1 reference

12 December 2020

Physiological parameters in laboratory animals and humans

1 reference

12 December 2020

Pharmacokinetics and pharmacodynamics of erythropoietin receptor in healthy volunteers

1 reference

12 December 2020

Evidence for a novel in vivo control mechanism of granulopoiesis: mature cell-related control of a regulatory growth factor

1 reference

12 December 2020

Population pharmacokinetic-pharmacodynamic modeling of filgrastim (r-metHuG-CSF) in healthy volunteers.

1 reference

12 December 2020

Clinical applications of granulocyte-colony stimulating factor

1 reference

12 December 2020

Rational cytokine design for increased lifetime and enhanced potency using pH-activated "histidine switching".

1 reference

12 December 2020

Effect of recombinant granulocyte colony-stimulating factor on neutrophil kinetics in normal young and elderly humans

1 reference

12 December 2020

Effect of escalating doses of recombinant human granulocyte colony-stimulating factor (filgrastim) on circulating neutrophils in healthy subjects

1 reference

12 December 2020

Levels of serum granulocyte colony-stimulating factor in patients with infections

1 reference

12 December 2020

Human granulocyte colony-stimulating factor: biologic activities and receptor characterization on hematopoietic cells and small cell lung cancer cell lines

1 reference

12 December 2020

Receptor-mediated clearance of G-CSF derivative nartograstim in bone marrow of rats

1 reference

12 December 2020

Parsing the effects of binding, signaling, and trafficking on the mitogenic potencies of granulocyte colony-stimulating factor analogues

1 reference

12 December 2020

Pharmacokinetic and pharmacodynamic analysis of subcutaneous recombinant human granulocyte colony stimulating factor (lenograstim) administration

1 reference

12 December 2020

A procedure for generating bootstrap samples for the validation of nonlinear mixed-effects population models.

1 reference

12 December 2020

Reduce, reuse, and recycle

1 reference

12 December 2020

10.2165/11318090-000000000-00000

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19902989%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

12 February 2020

1032772020

0 references

1 reference